Controversy over estrogen in Brazil after covexin, આરો 1 bribe per dose

- Brazil had earlier suspended a deal with India Biotech for covexin

New delhi date. Thursday, July 01, 2021

After the covacin vaccine, the Brazilian government is now besieging the estrogen vaccine. There may also be irregularities in the purchase of the AstraZeneca vaccine, according to Brazilian media reports. According to a report, the Bolshevik government demanded a bribe for each dose of the AstraZeneca vaccine.

A bribe of US 1 1 per dose of the AstraZeneca vaccine has been demanded, according to a Brazilian newspaper. However these claims have been refuted by AstraGeneca. The company says it does not work with any intermediaries in Brazil. All agreements are made directly through the Fiocruz (Oswaldo Cruise Foundation) and the federal government.

Davati Medical Supplies reportedly asked for a portfolio of 400 million doses of the AstraZeneca vaccine, with each dose costing 3.5. A single dose later cost 15.5. A ડો 1 bribe is being claimed for 400 million doses.

Covexin deal suspended

Brazil had earlier suspended a deal with India Biotech for covexin. In Brazil, the deal was being questioned so much that the 32 320 million contract was suspended. According to the allegation, the expensive vaccine deal was done under the pressure of the Ministry of Health.

Ever since the news of the deal broke out in Brazil, President Zaire Bolsenaro has been the talk of the town. A parliamentary panel is also investigating Koro's management and the issue was raised against him. The question was, even though Brazil had the option to buy Pfizer vaccine, it bought expensive vaccine from Bharat Biotech.